EUVIMEDEUVIMED entdecken
Qualitative StudieOpen Access

Generative AI Chatbot for Diabetes Management: Formative 2-Part Qualitative Study Using DTalksBot Involving Patients and Clinicians

Soyun Jeon iD, Seolhee Lee iD, Esther Hehsun Kim iD, Jinsu Eun iD, Kwangwon Lee iD, Hajin Lim iD, Joonhwan Lee iD

JMIR Formative Research · 12.11.2025 · 9 · e72553

DOI: 10.2196/72553 ↗

Kurz gefasst

Qualitative Studie in der Zeitschrift JMIR Formative Research, online erschienen am 12.11.2025. Verfasst von Soyun Jeon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Communication, Seoul National University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Artificial Intelligence, Diabetes Mellitus, Self-Management. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetes mellitus requires continuous self-management to prevent complications. Patients frequently rely on online resources and mobile apps for diabetes-related information; however, these often lead to information overload, limited personalization, and difficulty in navigation. Generative artificial intelligence (AI) chatbots may address these challenges by providing accessible, personalized, and responsive guidance.

Objective

This study aimed to explore the potential role of generative AI chatbots in diabetes management through a 2-part qualitative evaluation. Part 1 examined patients’ information needs, user experiences, and expectations. Part 2 investigated specialists’ perspectives on the practical utility of generative AI chatbots in supporting diabetes self-management. By incorporating perspectives from both patients and specialists, the study aimed to identify appropriate boundaries for the involvement of generative AI chatbots, reflecting the needs and expectations of both stakeholder groups.

Methods

This study was conducted using DTalksBot, a generative AI chatbot powered by GPT-4 (OpenAI) and enhanced with retrieval-augmented generation. In Part 1, we aimed to understand the experiences, needs, and expectations of patients with diabetes. To achieve this, 24 participants engaged in structured chatbot sessions, completed postinteraction surveys, and participated in in-depth interviews. Data were analyzed using thematic and content analysis to identify patterns in user queries and experiences. In part 2, we invited 4 family medicine specialists to assess the accuracy of DTalksBot’s responses by reviewing conversation logs and to share expert insights on the future role of generative AI chatbots in diabetes management.

Results

In part 1, a total of 24 patients submitted a total of 643 questions, which were categorized into 4 primary themes: personalized health advice and guidance (n=281, 44.6%), complications and comorbidities (n=174, 27.1%), medication and treatment exploration (n=111, 17.3%), and mental health management and support (n=30, 4.7%). Patients emphasized the advantages of generative AI chatbots over traditional information sources, including faster access to reliable content, reduced cognitive burden, and the ability to comfortably discuss sensitive topics. In part 2, specialists recognized the generative AI chatbots’ value in answering routine inquiries, but noted limitations in contextual accuracy, real-time data integration, and response personalization.

Conclusions

Generative AI chatbots showed promise as complementary tools for diabetes self-management by offering accessible, reliable, and tailored support. This formative evaluation provides empirical evidence on how generative AI chatbots can address patient information needs and complement existing health care resources. To maximize utility, future generative AI chatbots need to integrate real-time health data, enhance contextual relevance, and align with clinical workflows to ensure safety, trust, and broader applicability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceDiabetes MellitusSelf-ManagementHumansQualitative ResearchMaleFemaleMiddle AgedAdultAgedMobile ApplicationsGenerative Artificial Intelligence

Stichwörter der Autor:innen

diabetes managementdiabetes mellitusgenerative AI chatbotlarge language models (LLMs)online health information seekingretrieval-augmented generation (RAG)

Autor:innen und Institutionen

  • Department of Communication, Seoul National University, Seoul, Republic of Korea.
  • Department of Transdisciplinary Studies, Seoul National University, Seoul, Republic of Korea.
  • Interdisciplinary Program in Artificial Intelligence, Seoul National University, Seoul, Republic of Korea.

ORCID-Profile: Soyun Jeon, Seolhee Lee, Esther Hehsun Kim, Jinsu Eun, Kwangwon Lee, Hajin Lim, Joonhwan Lee

Zitieren

APA

Jeon, S., Lee, S., Kim, E. H., Eun, J., Lee, K., Lim, H., & Lee, J. (2025). Generative AI Chatbot for Diabetes Management: Formative 2-Part Qualitative Study Using DTalksBot Involving Patients and Clinicians. JMIR Formative Research, 9, e72553. https://doi.org/10.2196/72553

Vancouver

Jeon S, Lee S, Kim EH, Eun J, Lee K, Lim H, et al. Generative AI Chatbot for Diabetes Management: Formative 2-Part Qualitative Study Using DTalksBot Involving Patients and Clinicians. JMIR Formative Research. 2025;9:e72553. doi:10.2196/72553

BibTeX
@article{Jeon2025,
  author = {Jeon, Soyun and Lee, Seolhee and Kim, Esther Hehsun and Eun, Jinsu and Lee, Kwangwon and Lim, Hajin and Lee, Joonhwan},
  title = {Generative AI Chatbot for Diabetes Management: Formative 2-Part Qualitative Study Using DTalksBot Involving Patients and Clinicians},
  journal = {JMIR Formative Research},
  year = {2025},
  volume = {9},
  pages = {e72553},
  doi = {10.2196/72553}
}
Kostenlos starten →